Status:
TERMINATED
A Quality of Life Study in Patients With Migraines
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Rush University Medical Center
GlaxoSmithKline
Conditions:
Migraine
Headache
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to compare depressive characteristics in migraine patients to those observed in patients with epilepsy in a previous study, and determine whether those symptoms are unique...
Detailed Description
A form of depression known as dysphoric-like disorder is common in people with epilepsy, which may significantly affect the quality of life in these people, as shown in a previous study. However, it i...
Eligibility Criteria
Inclusion
- Male or female 18 years of age or older
- Have the diagnosis of migraine
- Have had no change in migraine medication(s) 30 days prior to study
- Achieve a satisfactory score on the Wide Range Achievement Test 3 (WRAT3) test at the screening visit
- Capable of completing self-reporting questionnaires
- Willing and able to provide written informed consent and comply with the study protocol
Exclusion
- Presence of a clinically significant comorbidity of an unstable or progressive nature
- Presence of major depression
- Participation in an investigational drug study within the past 30 days
- Inability to communicate well with site study personnel
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00298805
Start Date
January 1 2006
End Date
April 1 2013
Last Update
August 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
North Shore Long Island Jewish Health System
Great Neck, New York, United States, 11021